In June, 2017, Hepatoma Research (HR) enters a new era with the change of its Editor-in-Chief (EIC). After two years as the EIC of HR, Prof. Joseph. F. Buell stepped back and was appointed as the Founding Editor-in-Chief of the journal by OAE Publishing Inc. Former associate editor, Prof. Guang-Wen Cao, was elected as the new EIC with a term of two years.
Over the past two years, Prof. Buell has been an extremely effective EIC during the period of time when HR faced many challenges and changes since its launch. Under Prof. Buell’s great support and guidance, HR maintained a stable development momentum and became widely accepted inthescientific community and the periodicals industry, with a good influential presence in the international mainstream retrieval system. By June 16, 2017, 99 articles had been published online with increasing numbers of viewing and downloading. We all owe Prof. Buell and other editorial board members an enormous debt of gratitude for the effort and professional way that they have handled topic selection, peer-review, promotion, and other publication issues while under the double pressure of research and management work over the past two years.
To accelerate HR's development and to enhance its overall strength, OAE Publishing Inc. reorganized the editorial board from April to June 2017, and Prof. Guang-Wen Cao superseded Prof. Buell as the new EIC of HR as of June 6, 2017. Prof Cao will manage 68 editorial board members after reorganization, with a term of two years. Prof. Cao was an associate editor under the leadership of Prof. Buell from 2015 to 2017 and was a major contributor in maintaining the quality, timelines, and standards of HR. Our journal is very fortunate to be led by Prof. Cao, and we are conﬁdent that the quality of HR will continue to beneﬁt from his leadership and his collaboration with the members of the editorial ofﬁce and editorial board. We look forward to prospering and growing into an influential academic journal in the liver cancer research field. Given Prof. Cao's long and productive history in the field of liver diseases, we anticipate that he will be able to leverage all of his experiences to lead HR forward successfully.
Prof. Guang-Wen Cao, Chief scientist of National Key Basic Research Program of China. He is a fund winner of Chinese National Funds for Distinguished Youth, a national candidate of New Century Talents Project. He also holds a concurrent post of Vice President of Cancer Epidemiology Committee of China Anti-Cancer Association, Standing Committee Member of Cancer Etiology Branch of Chinese Anti-Cancer Association, Standing Committee Member of Society of Tumor Metastasis, China Anti-Cancer Association, Vice Chairman of Shanghai Preventive Medicine Association, China.
Prof. Cao carried out his researches mainly on mechanism of Hepatitis B virus oncogenesis, mechanism of inflammatory carcinogenesis, natural focal disease and Disaster Medicine. In 2005, with his direction, the doctoral degree point of first-class discipline "Public Health and Preventive Medicine" was established, setting up the "Disaster Medicine" and the "Navy Epidemiology" teaching system. Prof. Cao shouldered many national research tasks including: the Chinese National Key Basic Research Program (973 program), Chinese National Funds for Distinguished Youth, key international cooperation projects in China, etc. About 120 of his published articles are indexed in SCI. He published over 100 articles in J ClinOncol (in 2013) (IF=21), Gut (in 2008, 2009, 2014) (IF=15), J Natl Cancer Inst (in 2009) (IF=13), Hepatology (in 2013) (IF=12) and Am J Gastroenterol (in 2011) (IF=10) as the corresponding author. More than 33 of his articles were published in journals with IFs over 5.0. He published 15 articles in Nat Genet, Gastroenterology and Hepatology which are indexed in SCI. All his published articles have been cited more than 3,000 times.